株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ニコチン中毒:世界の治験レビュー

Nicotine Addiction Global Clinical Trials Review, H2, 2016

発行 GlobalData 商品コード 232277
出版日 ページ情報 英文 196 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
ニコチン中毒:世界の治験レビュー Nicotine Addiction Global Clinical Trials Review, H2, 2016
出版日: 2016年10月31日 ページ情報: 英文 196 Pages
概要

当レポートでは、ニコチン中毒の治療薬に関する治験について調査分析し、最新動向、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどについて、体系的な情報を提供しています。

目次

イントロダクション

地域別の治験

  • 国別の治験動向
    • アジア太平洋地域の主要国
    • 欧州の主要国
    • 北米の主要国
    • 中東・アフリカの主要国
    • 中南米の主要国

G7諸国における治験:中枢神経系の治験に対するニコチン中毒の割合

G7諸国における治験:相別

G7諸国における治験:段階別

E7諸国における治験:中枢神経系の治験に対するニコチン中毒の割合

E7諸国における治験:相別

E7諸国における治験:段階別

相別の治験

段階別の治験

評価項目別の治験

未完了の治験

一定期間に採用された被験者

スポンサータイプ別の治験

有望なスポンサー

  • ニコチン中毒の治療薬の治験に参加している主要企業

有望薬

治験プロファイル

  • 主要企業の治験概要
    • Johnson & Johnson
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Nabi Biopharmaceuticals (休止中)
    • Omeros Corporation
    • Star Scientific, Inc.
    • Rock Creek Pharmaceuticals INC
    • FORUM Pharmac
  • 主要大学・研究機関・病院の治験概要
    • National Institute on Drug Abuse
    • University of Pennsylvania
    • Yale University
    • Mayo Clinic
    • Centre for Addiction and Mental Health
    • University of Wisconsin Madison
    • Mclean Hospital
    • Massachusetts General Hospital
    • Duke University
    • University of California, San Francisco

主な臨床プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC3844CTIDB

GlobalData's clinical trial report, "Nicotine Addiction Global Clinical Trials Review, H2, 2016" provides an overview of Nicotine Addiction clinical trials scenario. This report provides top line data relating to the clinical trials on Nicotine Addiction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Nicotine Addiction to Central Nervous System Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Nicotine Addiction to Central Nervous System Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Nicotine Addiction Therapeutics Clinical Trials 27
  • Prominent Drugs 29
  • Clinical Trial Profile Snapshots 30

Appendix 193

  • Abbreviations 193
  • Definitions 193
  • Research Methodology 194
  • Secondary Research 194
  • About GlobalData 195
  • Contact Us 195
  • Disclaimer 195
  • Source 196

List of Tables

  • Nicotine Addiction Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Nicotine Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Nicotine Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9
  • Nicotine Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Nicotine Addiction Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Nicotine Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
  • Nicotine Addiction Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
  • Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14
  • Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17
  • Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Nicotine Addiction Therapeutics, Global, Clinical Trials by Phase, 2016* 20
  • Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
  • Nicotine Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Nicotine Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures

  • Nicotine Addiction Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Nicotine Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Nicotine Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 9
  • Nicotine Addiction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Nicotine Addiction Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Nicotine Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
  • Nicotine Addiction Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 13
  • Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14
  • Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Nicotine Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Nicotine Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17
  • Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Nicotine Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Nicotine Addiction Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
  • Nicotine Addiction Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
  • Nicotine Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Nicotine Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • Nicotine Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
  • GlobalData Methodology 194
Back to Top